OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
Agnieszka Mikłosz, Adrian Chabowski
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 8, pp. 1889-1897
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications
Monika Kamińska, Maria Jasiewicz, Magdalena Miernik-Skrzypczak, et al.
Quality in Sport (2025) Vol. 37, pp. 57420-57420
Open Access

The secretion of TGF-β3 by adipose-derived stem cells inhibits melanin synthesis and its impact on the cAMP/PKA signaling pathway
Xiaoyan Miao, Sheng Qu, Ziyi Guo, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access

Adipose stem cells ameliorate erectile dysfunction in diabetes mellitus rats by attenuating ferroptosis through NRP1 with SLC7A11 interaction
Junqi Luo, Li Wang, Zi-Qi Liao, et al.
Free Radical Biology and Medicine (2025) Vol. 232, pp. 40-55
Closed Access

Adipose stromal cells increase insulin sensitivity and decrease liver gluconeogenesis in a mouse model of type 1 diabetes mellitus
Hsiao-Chi Lai, Yen-Ju Lee, Pei-Hsuan Chen, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access

New insights on mesenchymal stem cells therapy from the perspective of the pathogenesis of nonalcoholic fatty liver disease
Yanxuan Wen, Jiaxing Li, Omar Mukama, et al.
Digestive and Liver Disease (2025)
Closed Access

Liraglutide Attenuates High Glucose-Induced Endothelial Cell Senescence and Dysfunction via SIRT1-Mediated Deacetylation of p53/p65
Weili Zhong, Ying Yang, Wang Yanru
Tissue and Cell (2025), pp. 102882-102882
Closed Access

Adipose Tissue-Derived Extracellular Vesicles: A Promising Biomarker and Therapeutic Strategy for Metabolic Disorders
Wenhui Liu, Tianyan Liu, Qingyu Zhao, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 9

Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 3

Novel lipid mediator 7S,14R-docosahexaenoic acid: biogenesis and harnessing mesenchymal stem cells to ameliorate diabetic mellitus and retinal pericyte loss
Yan Lu, Haibin Tian, Hongying Peng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

Adipose tissue place of origin and obesity influence sphingolipid signaling pathway in the adipocytes differentiated from ADMSCs isolated from morbidly obese women
Bartłomiej Łukaszuk, Elżbieta Supruniuk, Adrian Chabowski, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116158-116158
Open Access | Times Cited: 2

Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro
Marwa Mahmoud, Mazen Abdel‐Rasheed, Eman Reda Galal, et al.
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 175-205
Open Access | Times Cited: 6

Efficacy of adipose‐derived mesenchymal stem cell therapy in the treatment of chronic micro‐ and macrovascular complications of diabetes
Agnieszka Mikłosz, Adrian Chabowski
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 3, pp. 793-808
Open Access | Times Cited: 6

Silencing of forkhead box protein O-1 (FOXO-1) enhances insulin-producing cell generation from adipose mesenchymal stem cells for diabetes therapy
Mohamed M. Kamal, Reham A. Ammar, Dina H. Kassem
Life Sciences (2024) Vol. 344, pp. 122579-122579
Closed Access | Times Cited: 1

The effect of diabetes mellitus on differentiation of mesenchymal stem cells into insulin-producing cells
Omar I. Badr, Mohamed M. Kamal, Shohda A. El‐Maraghy, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1

Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome
Mojtaba Sarvestani, Alireza Rajabzadeh, Tahereh Mazoochi, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

NEDD4L-mediated RASGRP2 suppresses high-glucose and oxLDL-induced vascular endothelial cell dysfunctions by activating Rap1 and R-Ras
Guozhu Chen, Yisong Pei, Qiaoling Ye, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119844-119844
Closed Access | Times Cited: 1

Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives
Alaa Zeinhom, Sahar A. Fadallah, Marwa Mahmoud
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top